Cargando…
Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
Autores principales: | Janapala, Rajesh Naidu, Patel, Jigar, Belfaqeeh, Omar, Alhashmi, Abdulla, Pourmand, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083090/ https://www.ncbi.nlm.nih.gov/pubmed/33914266 http://dx.doi.org/10.1007/s40121-021-00443-5 |
Ejemplares similares
-
Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium
por: Patel, Jigar, et al.
Publicado: (2021) -
Novaferon, treatment in COVID-19 patients
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021) -
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021) -
COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London
por: Alhashmi, A., et al.
Publicado: (2021) -
Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)